Sign in

You're signed outSign in or to get full access.

Jostein Solheim

About Jostein Solheim

Independent Class I director at First Watch Restaurant Group (FWRG); age 59, director since December 2023. Currently CEO, Health & Wellbeing at Unilever PLC (since June 2021), and previously President, Food & Refreshments, North America at Unilever (2018–2021) and EVP/CEO of Ben & Jerry’s (2010–2018), with 32 years at Unilever in marketing, brand development and strategy. The Board affirms his independence under Nasdaq rules and nominates him for re‑election to a three‑year term ending at the 2028 annual meeting .

Past Roles

OrganizationRoleTenureCommittees/Impact
Unilever PLCCEO, Health & WellbeingJun 2021–presentExecutive leadership in portfolio building across wellness categories
Unilever (Food & Refreshments, North America)PresidentJul 2018–Jun 2021P&L leadership; consumer brand strategy
Ben & Jerry’s (Unilever subsidiary)EVP and CEOApr 2010–Jul 2018Led mission-driven brand; social and environmental responsibility emphasis

External Roles

OrganizationRoleTenureNotes
Unilever PLCCEO, Health & WellbeingJun 2021–presentExecutive role; no other public company directorships disclosed for Solheim

Board Governance

  • Committee assignments: Audit Committee member; qualifies as an “Audit Committee financial expert” under Item 407(d)(5). Audit Committee met 4 times in FY2024 and acted by written consent once; Chair is Charles Jemley .
  • Independence and class: Independent director under Nasdaq rules; Class I director; nominated for re‑election to 2028 .
  • Attendance: Board held 5 meetings in FY2024 (plus 6 written consents); each director attended at least 75% of Board and applicable committee meetings .
  • Board/committee independence: All committees comprised entirely of independent directors; Audit members meet heightened independence under Nasdaq and Rule 10A‑3 .
  • Chair/lead independent: Board Chair is Ralph Alvarez (not Solheim) .

Fixed Compensation

Component (FY2024 actual)Amount (USD)
Cash fees (retainer + committee membership)$80,000
Equity: RSUs grant-date fair value$100,000
Total$180,000
Non‑Employee Director Compensation FrameworkFY2024FY2025 (effective start of fiscal year)
Base cash retainer$75,000 $80,000
Audit Committee member / Chair$10,000 / $20,000 $15,000 / $30,000
Compensation Committee member / Chair$7,500 / $15,000 $12,500 / $25,000
Nominating & Governance member / Chair$6,000 / $10,000 $11,000 / $22,000
Annual RSU grant (non‑Advent directors)$100,000; Chair +$50,000 Base increased to $140,000; Chair +$60,000 (effective Jul 2024)

Equity grants vest on the first anniversary of the grant date, subject to continued Board service; number of RSUs calculated using the closing price the day following the annual meeting (May 23, 2024 price $19.25), rounded down to whole shares .

Performance Compensation

Equity Award Detail (FY2024)Grant basisNumber/ValueVestingPerformance Metrics
RSUs (annual)Grant-date fair value and closing price $19.25 on May 23, 2024$100,000; 5,194 RSUs (calc $100,000 / $19.25) 1-year cliff (first anniversary), continued service required None disclosed; time-based RSUs only

Other Directorships & Interlocks

CompanyRoleCommittee RolesInterlocks/Notes
No other public company boards disclosed for Solheim; Board confirms independence despite Advent affiliations for other directors

Expertise & Qualifications

  • Retail/hospitality operations (● integral) and consumer marketing/brand building (● integral), franchising (● integral), C‑suite/executive management (● integral), social & environmental responsibility (● integral) .
  • Meaningful involvement: information technology/cybersecurity (○), supply chain (○), real estate development (○), M&A/business development (○), corporate governance (○), finance & accounting (○), human capital (○) .

Equity Ownership

ItemQuantity/Value
Beneficial ownership (as of record date)10,457 shares; <1% of outstanding (base 60,968,674 shares)
Unvested RSUs held (as of Dec 29, 2024)5,194 RSUs
Stock optionsNone
Hedging/pledgingProhibited by Insider Trading Policy (no hedging, pledging, margin, short sales; no options trading)

Compensation Mix (FY2024)

MixCashEquity
Dollar amount$80,000 $100,000
Percent of total44% (derived)56% (derived)

Governance Assessment

  • Board effectiveness: Solheim strengthens Audit oversight as a designated financial expert; Audit met 4 times with one written consent in FY2024, aligning with strong financial controls and risk oversight . Attendance thresholds met across the Board .
  • Independence and conflicts: Board affirms his independence; Related Person Transaction Policy requires Audit Committee review/approval of any related-party transactions; none >$120,000 since the prior fiscal year—reduces conflict risk .
  • Alignment: Annual RSU grants with 1‑year vesting and prohibition on hedging/pledging support shareholder alignment and discourage short‑termism; no director options currently held by Solheim .
  • Pay structure: Balanced cash/equity with increased framework levels in FY2025 for committee service reflects workload and expertise; no performance metrics tied to director equity (RSUs are time-based) .
  • Compensation committee practices: Compensation Committee fully independent and empowered to retain independent advisers; no interlocks with other companies by FWRG executive officers reported in FY2024, limiting cross‑company influence risk .
  • Say‑on‑pay context: As an emerging growth company, FWRG does not conduct say‑on‑pay votes, moderating external feedback mechanisms on executive compensation; director pay is disclosed and standardized .

Red Flags: None disclosed specific to Solheim. No related‑party transactions, hedging/pledging, or attendance shortfalls indicated; note his concurrent Unilever executive role could create informational interlocks if Unilever were a material supplier/customer, but no such relationships are disclosed in FWRG filings .